WELLINGTON MANAGEMENT GROUP LLP

Position in BEAM — Beam Therapeutics Inc.

CIK 902219 Boston, MA

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,246,192

+$321,019 QoQ

Shares Held

36,311

-6.5% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#103

of 274 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0% Shared 94% None 6%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. BEAM ranks #144 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,247,658	$1,613,209,155
2	ARGX	Argenx SE	930,548	$863,334,513
3	REGN	Regeneron Pharmaceuticals, Inc.	1,270,087	$791,950,042
4	RVMD	Revolution Medicines, Inc.	3,843,415	$719,794,757
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,110,407	$635,295,816
6	IONS	Ionis Pharmaceuticals Inc	7,651,415	$606,680,693
7	CYTK	Cytokinetics Inc	6,931,770	$590,517,483
8	MDGL	Madrigal Pharmaceuticals, Inc.	825,714	$443,367,129

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,246,192	36,311	-6.5%	Shares	Defined	2026-08-14
2026-03-31	$925,173	38,824	+5.2%	Shares	Defined	2026-05-15
2025-12-31	$1,022,921	36,902	-2.9%	Shares	Defined	2026-02-17
2025-09-30	$921,967	37,988	+1.9%	Shares	Defined	2025-11-14
2025-06-30	$633,910	37,267	+10.8%	Shares	Defined	2025-08-14
2025-03-31	$656,812	33,631	-5.4%	Shares	Defined	2025-05-13
2024-12-31	$882,110	35,569	-8.8%	Shares	Defined	2025-02-12
2024-09-30	$955,401	38,996	-9.5%	Shares	Defined	2024-11-14
2024-06-30	$1,010,019	43,108	+30.8%	Shares	Defined	2024-08-14
2024-03-31	$1,088,764	32,953	+57.5%	Shares	Defined	2024-05-15
2023-12-31	$569,332	20,916	-89.2%	Shares	Defined	2024-02-12
2020-12-31	$15,750,885	192,931	+310.5%	Shares	Defined	2021-02-12
2020-09-30	$1,157,140	47,000	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.